David Rickey, Director at CYTORI THERAPEUTICS, INC. (CYTX), bought 7,000 shares at $2.35 ($16K) on 2011-12-08, disclosed to the SEC on 2011-12-08.
Open-market purchase of $16k CYTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.31 | 3,000 | $7K | 42.5% |
| 2 | $2.34 | 2,000 | $5K | 28.7% |
| 3 | $2.35 | 2,000 | $5K | 28.8% |
| Total | $2.33 avg | 7,000 | $16K | 100% |
| Filing → |
| CYTX | BUY | 2015-08-31 | $17K | — | Filing → |
| CYTX | BUY | 2015-08-28 | $23K | — | Filing → |
| CYTX | BUY | 2015-08-24 | $19K | — | Filing → |